These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6412008)

  • 21. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
    Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
    Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The iron concentration in the blood of patients with postoperative feeding tube].
    Wilke J; Rentzsch G
    Z Laryngol Rhinol Otol; 1969 Sep; 48(9):710-7. PubMed ID: 4982012
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combined cytostatic-radiologic therapy of advanced malignant tumors in otorhinolaryngology. Experiences and results with over 100 patients].
    Dietz R; Wilhelm HJ
    Laryngol Rhinol Otol (Stuttg); 1981 Feb; 60(2):85-8. PubMed ID: 7218993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum micronutrients and upper aerodigestive tract cancer.
    Nomura AM; Ziegler RG; Stemmermann GN; Chyou PH; Craft NE
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):407-12. PubMed ID: 9184773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of acid and alkaline reflux in laryngeal squamous cell carcinoma.
    Galli J; Cammarota G; Calò L; Agostino S; D'Ugo D; Cianci R; Almadori G
    Laryngoscope; 2002 Oct; 112(10):1861-5. PubMed ID: 12368631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunohistochemical findings in intrathoracic tumors. II. Demonstration of alpha 1-antitrypsin in tumor tissue].
    Eckert H
    Z Erkr Atmungsorgane; 1983; 161(3):319-24. PubMed ID: 6367241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preradiotherapy hemoglobin level but not microvessel density predicts locoregional control and survival in laryngeal cancer treated with primary radical radiotherapy.
    Haugen H; Magnusson B; Svensson M; Mercke C
    Clin Cancer Res; 2004 Dec; 10(23):7941-9. PubMed ID: 15585628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)].
    Kasprzyk M; Dyszkiewicz W; Zwaruń D; Szydlik S; Leśniewska K; Krzyzanowski M
    Przegl Lek; 2006; 63(10):936-40. PubMed ID: 17288188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypercoagulability in pharyngolaryngeal cancers].
    Viry-Babel F; Simon C; Pincemaille B; Alexandre P; Wayoff M
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1982 Sep; 31(7):487-92. PubMed ID: 6216316
    [No Abstract]   [Full Text] [Related]  

  • 31. Alpha-1 antitrypsin (alpha1-AT) plasma levels in lung, prostate and breast cancer patients.
    El-Akawi ZJ; Al-Hindawi FK; Bashir NA
    Neuro Endocrinol Lett; 2008 Aug; 29(4):482-4. PubMed ID: 18766166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of serum alpha-antitrypsin deficiency].
    Roehr EE; de Obrutsky CW
    Medicina (B Aires); 1974; 34(5):451-6. PubMed ID: 4215935
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
    Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
    Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of elevated osteopontin levels in head and neck cancer patients.
    Eto M; Kodama S; Nomi N; Uemura N; Suzuki M
    Auris Nasus Larynx; 2007 Sep; 34(3):343-6. PubMed ID: 17254728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Kallikrein and prekallikrein content and antitryptic activity in the blood serum in serum hepatitis of varying degrees of severity].
    Iakubovskaia RI; Malyshev NA; Farber NA; Didkovskiĭ NA; Paskhina TS
    Vopr Med Khim; 1981; 27(6):804-11. PubMed ID: 6977940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of bioantioxidants depression and deficiency of protease inhibitor alpha 1-antitrypsin in mechanisms activating free radical oxidation and proteolysis in chronic pancreatitis].
    Zhukova EN
    Ter Arkh; 2000; 72(2):29-31. PubMed ID: 10717921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-1 antitrypsin binds preprohepcidin intracellularly and prohepcidin in the serum.
    Pandur E; Nagy J; Poór VS; Sarnyai A; Huszár A; Miseta A; Sipos K
    FEBS J; 2009 Apr; 276(7):2012-21. PubMed ID: 19292870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycoprotein electrophoretic pattern in sera of patients with oral precancerous conditions and upper aerodigestive tract cancer.
    Patel PS; Rawal RM; Raval GN; Patel BP; Patel YV; Shah SG; Balar DB; Patel DD
    J Exp Clin Cancer Res; 1997 Mar; 16(1):65-70. PubMed ID: 9148863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and treatment.
    Köhnlein T; Welte T
    Am J Med; 2008 Jan; 121(1):3-9. PubMed ID: 18187064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.